Search research articles
Contact Us
Filters
Showing results (581-590 of 626) with videos related to
Page
of 63
Sort By:
Antimicrobial Agents and Chemotherapy
|
June 20, 2012
TMC647055, a potent nonnucleoside hepatitis C virus NS5B polymerase inhibitor with cross-genotypic coverage
Benoit Devogelaere, Jan Martin Berke, Leen Vijgen, et al.
The Journal of Infection
|
September 19, 2018
Galectin-3 aggravates experimental polymicrobial sepsis by impairing neutrophil recruitment to the infectious focus
Raphael G Ferreira, Lilian C Rodrigues, Daniele C Nascimento, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 24, 2019
3-Substituted Quinolines as RORγt Inverse Agonists
Virginia M Tanis, Hariharan Venkatesan, Maxwell D Cummings, et al.
Antimicrobial Agents and Chemotherapy
|
February 24, 2010
In vitro resistance profile of the hepatitis C virus NS3/4A protease inhibitor TMC435
Oliver Lenz, Thierry Verbinnen, Tse-I Lin, et al.
Scientific Reports
|
May 4, 2017
IVIG regulates the survival of human but not mouse neutrophils
Christoph Schneider, Simone Wicki, Stefanie Graeter, et al.
Cell Death & Disease
|
December 8, 2017
Proteomic and functional analysis identifies galectin-1 as a novel regulatory component of the cytotoxic granule machinery
Tiago Clemente, Narcisio J Vieira, Juan P Cerliani, et al.
Glycobiology
|
September 20, 2017
GlyTouCan: an accessible glycan structure repository
Michael Tiemeyer, Kazuhiro Aoki, James Paulson, et al.
Journal of Medicinal Chemistry
|
October 28, 2005
Azepanone-based inhibitors of human cathepsin L
Robert W Marquis, Ian James, Jin Zeng, et al.
Circulation. Cardiovascular Quality and Outcomes
|
February 8, 2023
Validity of Patient-Reported Outcomes Measurement Information System Physical, Mental, and Social Health Measures After Left Ventricular Assist Device Implantation and Implications for Patient Care
Elizabeth A Hahn, Mary N Walsh, Larry A Allen, et al.
Journal of Medicinal Chemistry
|
October 23, 2013
Discovery and early development of TMC647055, a non-nucleoside inhibitor of the hepatitis C virus NS5B polymerase
Maxwell D Cummings, Tse-I Lin, Lili Hu, et al.
Page
of 63
Search research articles
Search
Showing results (581-590 of 626) with videos related to
Sort By:
Page
of 63
Antimicrobial Agents and Chemotherapy
|
June 20, 2012
TMC647055, a potent nonnucleoside hepatitis C virus NS5B polymerase inhibitor with cross-genotypic coverage
Benoit Devogelaere, Jan Martin Berke, Leen Vijgen, et al.
The Journal of Infection
|
September 19, 2018
Galectin-3 aggravates experimental polymicrobial sepsis by impairing neutrophil recruitment to the infectious focus
Raphael G Ferreira, Lilian C Rodrigues, Daniele C Nascimento, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 24, 2019
3-Substituted Quinolines as RORγt Inverse Agonists
Virginia M Tanis, Hariharan Venkatesan, Maxwell D Cummings, et al.
Antimicrobial Agents and Chemotherapy
|
February 24, 2010
In vitro resistance profile of the hepatitis C virus NS3/4A protease inhibitor TMC435
Oliver Lenz, Thierry Verbinnen, Tse-I Lin, et al.
Scientific Reports
|
May 4, 2017
IVIG regulates the survival of human but not mouse neutrophils
Christoph Schneider, Simone Wicki, Stefanie Graeter, et al.
Cell Death & Disease
|
December 8, 2017
Proteomic and functional analysis identifies galectin-1 as a novel regulatory component of the cytotoxic granule machinery
Tiago Clemente, Narcisio J Vieira, Juan P Cerliani, et al.
Glycobiology
|
September 20, 2017
GlyTouCan: an accessible glycan structure repository
Michael Tiemeyer, Kazuhiro Aoki, James Paulson, et al.
Journal of Medicinal Chemistry
|
October 28, 2005
Azepanone-based inhibitors of human cathepsin L
Robert W Marquis, Ian James, Jin Zeng, et al.
Circulation. Cardiovascular Quality and Outcomes
|
February 8, 2023
Validity of Patient-Reported Outcomes Measurement Information System Physical, Mental, and Social Health Measures After Left Ventricular Assist Device Implantation and Implications for Patient Care
Elizabeth A Hahn, Mary N Walsh, Larry A Allen, et al.
Journal of Medicinal Chemistry
|
October 23, 2013
Discovery and early development of TMC647055, a non-nucleoside inhibitor of the hepatitis C virus NS5B polymerase
Maxwell D Cummings, Tse-I Lin, Lili Hu, et al.
Page
of 63